Researchers from the Moscow Institute of Physics and Technology have created a device that acts like a synapse in the living brain, storing information and gradually forgetting it when not accessed for a long time.
Optalysys, a comapny which spelises in the development of optical processing technology, has announced the addition of Professor Thomas F Krauss to their Scientific Advisory Board
Clemson University has received an Nvidia DGX-2 supercomputer from Microway to boost its capabilities for research in AI and HPC applications
At the annual Fujitsu Innovation Gathering today in London, Fujitsu Laboratories of Europe today announces a new AI technology that enhances Electronic Health Record (EHR) management, automating the processing of unstructured (free text) medical notes and achieving time savings of more than 90 per cent with significantly improved accuracy.
DataDirect Networks (DDN) has announced its intent to acquire Nexenta, a provider of software defined storage (SDS) for 5G and Internet of Things (IoT), creating the Nexenta by DDN division
Ross Upton, CEO and academic co-founder at Ultromics, discusses the potential to implement AI in clinical diagnostics
McLaren Applied Technologies have unveiled their for the future of grand prix racing
Queen Mary University of London is leading a major new research project, ‘Living with Machines,’ which is set to be one of the biggest and most ambitious humanities and science research initiatives ever to launch in the UK
Sophia Ktori completes her two-part series on the use of artificial intelligence in healthcare research
Robert Roe reports on new technology and 30 years of the US supercomputing conference at SC18 in Dallas
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
